Viral Hepatitis Journal VİRAL HEPATİT DERGİSİ

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors,

Objectives: The aim of this study was to determine the frequency of blood-borne infections [hepatitis B virus (HBV), HCV, and human immunodeficiency virus (HIV)] and the

Objectives: The study aimed to investigate the seroprevalence of hepatitis B surface antigen (HBsAg) and hepatitis C virus (anti- HCV) in human immunodeficiency virus (HIV)

Distribution of hepatitis C virus genotypes among patients with chronic hepatitis C infection in Akdeniz University Hospital, Antalya, Turkey: A five-year evaluation. Kuscu F,

In this study, we retrospectively evaluated the results of test performed in the Central Laboratory of İstanbul Northern Anatolian Association of Public Hospitals to determine the

Ülkü ORAL ZEYTİNLİ, Fatma MUHTEREM YÜCEL, Şölen DALDABAN DİNÇER, Özgür YANILMAZ, Sebahat AKSARAY, Kamil ÖZDİL. Association of Public Hospitals Northern Anatolian Region

More recently, together with a combination of sofosbuvir 400 mg and ledipasvir 90 mg, the dual regimen of sofosbuvir 400 mg and daclatasvir 60 mg has raised up as a more

The aim of the present study was to investigate the seropositivity rates for HBV, anti-HBs, anti-HBc IgG, anti-HCV, and anti-HIV 1-2 among healthcare professionals at the